0001701523-18-000002.txt : 20181217 0001701523-18-000002.hdr.sgml : 20181217 20181217135032 ACCESSION NUMBER: 0001701523-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 504(b)(1)(iii) ITEM INFORMATION: 06b FILED AS OF DATE: 20181217 DATE AS OF CHANGE: 20181217 EFFECTIVENESS DATE: 20181217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Illuminare Biotechnologies Inc CENTRAL INDEX KEY: 0001701523 IRS NUMBER: 812564534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-328120 FILM NUMBER: 181237688 BUSINESS ADDRESS: STREET 1: 327 ST MARKS AVE CITY: BROOKLYN STATE: NY ZIP: 11238 BUSINESS PHONE: 6094971282 MAIL ADDRESS: STREET 1: 327 ST MARKS AVE CITY: BROOKLYN STATE: NY ZIP: 11238 D 1 primary_doc.xml X0708 D LIVE 0001701523 Illuminare Biotechnologies Inc 327 ST MARKS AVE BROOKLYN NY NEW YORK 11238 6094971282 DELAWARE None None Corporation true 2016 Walter Greenblatt 327 St Marks Ave Brooklyn NY NEW YORK 11238 Executive Officer Biotechnology No Revenues 06b 04.3 false 2018-12-17 false true false 5000 2500000 0 2500000 false 0 0 0 0 false Illuminare Biotechnologies Inc Andrew Fradkin Andrew Fradkin Secretary 2018-12-17